OptiBiotix Health Plc (OPTI.L)
GBp 19.0
(-9.52%)
GBp 19.0
(-9.52%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.69 Million GBP | 31.87% |
| 2022 | -2.48 Million GBP | -82.23% |
| 2021 | -1.36 Million GBP | -22.85% |
| 2020 | -1.11 Million GBP | 48.7% |
| 2019 | -2.16 Million GBP | -44.55% |
| 2018 | -1.49 Million GBP | 29.52% |
| 2017 | -2.12 Million GBP | -40.31% |
| 2016 | -1.51 Million GBP | -6.5% |
| 2015 | -1.42 Million GBP | -191.04% |
| 2014 | -489.01 Thousand GBP | -90.95% |
| 2013 | -256.1 Thousand GBP | 84.44% |
| 2012 | -1.64 Million GBP | 0.0% |
| 2010 | -39 Thousand GBP | -30.0% |
| 2009 | -30 Thousand GBP | 57.75% |
| 2008 | -71 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.06 Million GBP | 0.0% |
| 2023 FY | -1.69 Million GBP | 31.87% |
| 2023 Q4 | -935 Thousand GBP | 0.0% |
| 2023 Q2 | -760 Thousand GBP | 0.0% |
| 2022 Q2 | -1.04 Million GBP | 0.0% |
| 2022 Q4 | -1.44 Million GBP | 0.0% |
| 2022 FY | -2.48 Million GBP | -82.23% |
| 2021 FY | -1.36 Million GBP | -22.85% |
| 2021 Q2 | -596.78 Thousand GBP | 0.0% |
| 2021 Q4 | -768.53 Thousand GBP | 0.0% |
| 2020 FY | -1.11 Million GBP | 48.7% |
| 2020 Q2 | -599.19 Thousand GBP | 0.0% |
| 2020 Q4 | -512.2 Thousand GBP | 0.0% |
| 2019 Q4 | -1.2 Million GBP | 0.0% |
| 2019 FY | -2.16 Million GBP | -44.55% |
| 2019 Q2 | -962.99 Thousand GBP | 0.0% |
| 2018 FY | -1.49 Million GBP | 29.52% |
| 2018 Q4 | -521.39 Thousand GBP | 0.0% |
| 2018 Q2 | -977.5 Thousand GBP | 0.0% |
| 2017 FY | -2.12 Million GBP | -40.31% |
| 2017 Q4 | -1.14 Million GBP | 0.0% |
| 2017 Q2 | -980.84 Thousand GBP | 0.0% |
| 2016 Q4 | -802 Thousand GBP | 0.0% |
| 2016 Q2 | -713.83 Thousand GBP | 0.0% |
| 2016 FY | -1.51 Million GBP | -6.5% |
| 2015 FY | -1.42 Million GBP | -191.04% |
| 2015 Q2 | -514.43 Thousand GBP | 0.0% |
| 2015 Q4 | -908.82 Thousand GBP | 0.0% |
| 2014 Q2 | -57.64 Thousand GBP | 0.0% |
| 2014 FY | -489.01 Thousand GBP | -90.95% |
| 2014 Q4 | -431.37 Thousand GBP | 0.0% |
| 2013 Q4 | -89.64 Thousand GBP | 0.0% |
| 2013 FY | -256.1 Thousand GBP | 84.44% |
| 2013 Q2 | -166.45 Thousand GBP | 0.0% |
| 2012 FY | -1.64 Million GBP | 0.0% |
| 2012 Q2 | -411.53 Thousand GBP | 0.0% |
| 2012 Q1 | -411.53 Thousand GBP | 0.0% |
| 2011 Q4 | -411.53 Thousand GBP | 0.0% |
| 2010 Q1 | -9750.00 GBP | 0.0% |
| 2010 FY | -39 Thousand GBP | -30.0% |
| 2010 Q3 | -9750.00 GBP | 0.0% |
| 2010 Q2 | -9750.00 GBP | 0.0% |
| 2009 Q3 | -7500.00 GBP | 0.0% |
| 2009 Q2 | -7500.00 GBP | 0.0% |
| 2009 Q1 | -7500.00 GBP | 0.0% |
| 2009 FY | -30 Thousand GBP | 57.75% |
| 2009 Q4 | -9750.00 GBP | -30.0% |
| 2008 Q2 | -17.75 Thousand GBP | 0.0% |
| 2008 FY | -71 Thousand GBP | 0.0% |
| 2008 Q1 | -17.75 Thousand GBP | 0.0% |
| 2008 Q3 | -17.75 Thousand GBP | 0.0% |
| 2008 Q4 | -7500.00 GBP | 57.75% |
| 2007 Q4 | -17.75 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|